“Implementing Electronic Prescriptions for Controlled Substances“
Many healthcare providers have delayed implementing electronic prescriptions for controlled substances (EPCS). Some may be waiting for the regulatory dust to settle, as the US Drug Enforcement Agency (DEA) ruling is titled “Interim.” Others may be deterred by the length and complexity of the document. Despite the temporary title of the DEA’s ruling, EPCS is here to stay. With each passing month, the reasons for implementing it become more compelling. This paper’s aim is to help healthcare practitioners plan their EPCS efforts and start taking action.
All White Papers distributed by healthsystemCIO.com have been pre-approved for quality, CIO-level content. To access this document, please fill out and submit the registration form below. You will then be redirected to the download page. Your information will be shared with the sponsor, who may contact you regarding topics covered in this White Paper.
Register Here